Citigroup Inc. Lowers Holdings in The Cooper Companies, Inc. (NYSE:COO)

Citigroup Inc. reduced its stake in shares of The Cooper Companies, Inc. (NYSE:COOGet Rating) by 9.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,982 shares of the medical device company’s stock after selling 6,228 shares during the period. Citigroup Inc. owned 0.12% of Cooper Companies worth $24,291,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Veritas Asset Management LLP increased its position in Cooper Companies by 12.0% during the fourth quarter. Veritas Asset Management LLP now owns 2,001,678 shares of the medical device company’s stock worth $838,583,000 after purchasing an additional 214,700 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Cooper Companies by 35.7% during the 3rd quarter. Invesco Ltd. now owns 1,585,683 shares of the medical device company’s stock worth $655,378,000 after buying an additional 417,077 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Cooper Companies by 7.3% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,107,153 shares of the medical device company’s stock worth $457,599,000 after buying an additional 75,358 shares during the period. Victory Capital Management Inc. boosted its holdings in Cooper Companies by 18.2% in the fourth quarter. Victory Capital Management Inc. now owns 879,658 shares of the medical device company’s stock valued at $368,524,000 after acquiring an additional 135,506 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in Cooper Companies by 2.8% during the third quarter. Geode Capital Management LLC now owns 862,258 shares of the medical device company’s stock valued at $355,420,000 after acquiring an additional 23,609 shares during the period. 98.38% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Gary S. Petersmeyer sold 300 shares of the business’s stock in a transaction dated Monday, April 11th. The shares were sold at an average price of $410.55, for a total value of $123,165.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert S. Weiss sold 13,039 shares of the company’s stock in a transaction dated Tuesday, March 29th. The shares were sold at an average price of $415.24, for a total transaction of $5,414,314.36. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,646 shares of company stock worth $8,195,614. 1.70% of the stock is currently owned by corporate insiders.

Cooper Companies stock opened at $327.91 on Tuesday. The Cooper Companies, Inc. has a 12-month low of $309.43 and a 12-month high of $463.59. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.02 and a quick ratio of 0.67. The company has a market capitalization of $16.17 billion, a price-to-earnings ratio of 17.40, a price-to-earnings-growth ratio of 2.12 and a beta of 0.90. The firm’s fifty day moving average price is $388.85 and its 200 day moving average price is $398.42.

Cooper Companies (NYSE:COOGet Rating) last announced its earnings results on Thursday, March 3rd. The medical device company reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.10 by $0.14. The business had revenue of $787.20 million for the quarter, compared to analyst estimates of $739.30 million. Cooper Companies had a return on equity of 9.89% and a net margin of 31.00%. The company’s revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period in the previous year, the company earned $3.17 earnings per share. Analysts forecast that The Cooper Companies, Inc. will post 14.09 earnings per share for the current fiscal year.

A number of analysts have recently issued reports on the company. Stephens boosted their target price on Cooper Companies from $430.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, March 7th. Needham & Company LLC assumed coverage on shares of Cooper Companies in a research note on Friday, April 8th. They set a “hold” rating for the company. Piper Sandler raised their target price on shares of Cooper Companies from $490.00 to $500.00 in a research note on Friday, March 4th. Finally, StockNews.com began coverage on shares of Cooper Companies in a research report on Thursday, March 31st. They set a “hold” rating for the company. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Buy” and an average target price of $469.00.

Cooper Companies Company Profile (Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.